Lv71
3650 积分 2024-02-08 加入
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
1个月前
已完结
The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature
5个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
5个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
6个月前
已完结
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia
7个月前
已完结
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
7个月前
已完结
SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation
7个月前
已完结
Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors
7个月前
已完结
Prognostic factors and risk stratification in chronic lymphocytic leukemia
7个月前
已完结
SOHO State of the Art Updates and Next Questions | Covalent Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
7个月前
已完结
皖公网安备34019202002308
